Clinical Trials Logo

Filter by:
NCT ID: NCT05780463 Completed - COVID-19 Clinical Trials

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Start date: June 11, 2021
Phase: Phase 3
Study type: Interventional

This study looks at the safety and effectiveness of MP0420 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either MP0420 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H5.

NCT ID: NCT05771571 Completed - Clinical trials for Cardiometabolic Risk

Investigation of the Acute Effect of Novel Olive Oil on Postprandial Oxidative Stress Biomarkers (BioliveCT)

BioliveCT
Start date: May 12, 2022
Phase: N/A
Study type: Interventional

The purpose of this study was the investigation of the hypothesis that the enhancement of a refined olive oil with orange peel extract, may improve the postprandial lipidemic, glycemic profile and blood oxidative status, of volunteers with high cardiometabolic risk, due to increased content of bioactive compounds (polyphenols, carotenoids etc.).

NCT ID: NCT05765994 Completed - Critical Illness Clinical Trials

Small Intestinal Bacterial Overgrowth in Critically Ill Patients

Start date: November 19, 2018
Phase:
Study type: Observational

Small intestinal bacterial overgrowth (SIBO) syndrome, though associated with potentially serious complications, has not been adequately studied to date in critically ill patients hospitalized in intensive care units (ICU). A modified method for SIBO diagnosis is employed concerning a standard breath test. Specifically, as all participants are intubated and in need of mechanical ventilation, SIBO diagnosis is based on a non-invasive modified technique for sampling exhaled air from the ventilator tubes and performing a standard hydrogen breath test. The primary objective of this study is assessment of the prevalence of SIBO on ICU patients. Secondary outcomes include investigation of the effects of SIBO on ventilator associated pneumonia, as well as ICU length of stay and all-cause in-hospital mortality rate in critically ill patients.

NCT ID: NCT05757323 Completed - Growth Clinical Trials

The Effects of an Infant Formula Containing Hydrolysed Proteins on Growth and Tolerance in Healthy Term Infants

Start date: August 6, 2021
Phase: N/A
Study type: Interventional

In this clinical trial, weight gain (primary objective), and additional anthropometry (secondary objectives), of infants exclusively consuming a hydrolysed protein-based infant formula were evaluated and compared to a standard intact protein-based formula over a period of at least three months, until the age of 17 weeks.

NCT ID: NCT05736939 Completed - Clinical trials for Post Acute COVID-19 Syndrome

Gender Differences in the Recovery Rate Following PR in Patients With Long COVID-19

Start date: October 1, 2022
Phase:
Study type: Observational

The goal of this retrospective analysis is to compare the magnitude of improvement in respiratory and peripheral muscle strength, following the completion of a hybrid pulmonary rehabilitation programme, in men and women with long COVID-19 syndrome. The main question it aims to answer is the following: • does gender limits the effects of a hybrid pulmonary rehabilitation programme on respiratory and peripheral muscle strength?

NCT ID: NCT05734248 Completed - Aging Clinical Trials

Fractional Laser Drug Delivery of a Local Anesthetic

Start date: February 6, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the clinical efficacy of fractional CO2 laser-assisted delivery of a topically applied anesthetic to the perceived pain during filler injection.

NCT ID: NCT05733234 Completed - Peri-Implantitis Clinical Trials

Lasers in Peri-implantitis Treatment

Start date: May 20, 2021
Phase: N/A
Study type: Interventional

The current study aimed to investigate the effect of the combined Nd-Er: YAG laser on the surgical treatment of peri-implantitis by evaluating clinical markers and biomarkers of bone loss (RANKL/OPG). Twenty (20) patients having at least 1 implant diagnosed with peri-implantitis were randomly assigned to two groups for surgical treatment. In the test group (n=10), Er: YAG laser was used for granulation tissue removal and implant surface decontamination, while Nd: YAG laser was employed for deep tissue decontamination and biomodulation. In the control group (n=10), an access flap was applied, and mechanical instrumentation of the implant surface was performed by using titanium curettes. The following clinical parameters were evaluated at baseline and six months after treatment: Full-mouth Plaque Score (FMPS), Probing Pocket Depth (PPD), Probing Attachment Levels (PAL), recession (REC), and Bleeding on probing (BoP). Peri-implant crevicular fluid (PICF) was collected at baseline and six months for the evaluation of soluble RANKL and OPG utilizing enzyme-linked immunosorbent assay (ELISA).

NCT ID: NCT05729685 Completed - Healthy Clinical Trials

Aerobic Adaptations With Various Training Methods

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The goal of this intervention study is to compare the adaptations after a 6-week training period between an intense continuous and a high-intensity interval training program performed under iso-effort conditions on aerobic performance parameters in young healthy adults. The main question it aims to answer are if the intense continuous and a high-intensity interval training programs will induce similar adaptations in maximal (VO2max and PTV) and submaximal (critical velocity, lactate threshold parameters and running economy) aerobic performance parameters. Participants will be ere randomly assigned either to an intense continuous training group (CON) or to a high-intensity interval training group (INT). The training program will comprise of 14 training sessions performed over a 6-week period.

NCT ID: NCT05729659 Completed - Oxidative Stress Clinical Trials

Sideritis Supplementation, Oxidative Stress and Health

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

The aim of the present clinical study is to estimate the efficacy of a Sideritis Scardica extract (SidTea+), derived from the Greek mountain Taygetos, in regulating antioxidant and health biomarkers in healthy adults.

NCT ID: NCT05729204 Completed - SARS-CoV2 Infection Clinical Trials

Washing COVID-19 Away With a Hypertonic Seawater Nasal Irrigation Solution

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Nasal irrigations are thought to reduce the amount of virus from the nasal cavity. The aim of the present study is to evaluate the effect of a hypertonic seawater solution containing algal and herbal natural ingredients (Sinomarin®) on the nasopharyngeal viral load in hospitalized patients with severe COVID-19 pneumonia. The investigators will conducted a prospective, randomized, controlled trial. Patients will be allocated in two groups, the hypertonic seawater group receiving nasal irrigations with a hypertonic seawater solution (Sinomarin®) every 4 hours during a 16-hour interval per day, for two consecutive days, and the control group (no nasal irrigations). Forty-eight hours after the baseline nasopharyngeal swab (and 8 hours after the last wash in the hypertonic seawater group), a second nasopharyngeal swab will be collected for the semiquantitative estimation of the SARS-CoV-2 viral load as determined by cycle threshold (Ct) values.